Paper7876979
Plasmodium berghei: production and quantitation of hepatic stages derived from irradiated sporozoites in rats and mice.
Scheller LF and 2 others. J Parasitol, 1995. Cited by 19 papers, by iCite.
Cite this record
ConductScience Library. Plasmodium berghei: production and quantitation of hepatic stages derived from irradiated sporozoites in rats and mice. Papers, record 7876979. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/7876979
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics11
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Liver | Major topic |
| Malaria | Major topic |
| Plasmodium berghei | Major topic |
| Animals | |
| Female | |
| Immunization | |
| Malaria Vaccines | |
| Mice | |
| Mice, Inbred C57BL | |
| Rats | |
| Vaccines, Attenuated |
Source PubMed
Cited by8
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 19 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40424562 | Long lived liver-resident memory T cells of biased specificities for abundant sporozoite antigens drive malaria protection by radiation-attenuated sporozoite vaccination. | PLoS Pathog | 2025 | https://conductscience.org/library/papers/40424562 | PubMed |
| 37996533 | The effect of dosage on the protective efficacy of whole-sporozoite formulations for immunization against malaria. | NPJ Vaccines | 2023 | https://conductscience.org/library/papers/37996533 | PubMed |
| 22563506 | Long term protection after immunization with P. berghei sporozoites correlates with sustained IFNγ responses of hepatic CD8+ memory T cells. | PLoS One | 2012 | https://conductscience.org/library/papers/22563506 | PubMed |
| 17562804 | Pharmacokinetics, safety, and hydrolysis of oral pyrroloquinazolinediamines administered in single and multiple doses in rats. | Antimicrob Agents Chemother | 2007 | https://conductscience.org/library/papers/17562804 | PubMed |
| 16641431 | New potential antimalarial agents: therapeutic-index evaluation of pyrroloquinazolinediamine and its prodrugs in a rat model of severe malaria. | Antimicrob Agents Chemother | 2006 | https://conductscience.org/library/papers/16641431 | PubMed |
| 15901208 | Intravital observation of Plasmodium berghei sporozoite infection of the liver. | PLoS Biol | 2005 | https://conductscience.org/library/papers/15901208 | PubMed |
| 9284167 | Inhibition of nitric oxide interrupts the accumulation of CD8+ T cells surrounding Plasmodium berghei-infected hepatocytes. | Infect Immun | 1997 | https://conductscience.org/library/papers/9284167 | PubMed |
| 7732032 | Maintenance of protective immunity against malaria by persistent hepatic parasites derived from irradiated sporozoites. | Proc Natl Acad Sci U S A | 1995 | https://conductscience.org/library/papers/7732032 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/7876979
GET https://conductscience.org/api/papers/v1/7876979/authors